<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2023-12-31</publicationDate>
    
        <volume>20</volume>
        <issue>4</issue>

 
    <startPage>1419</startPage>
    <endPage>1432</endPage>

	 
      <doi>10.13005/bbra/3187</doi>
        <publisherRecordId>48517</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Formulation and Evaluation of Biopolymer Incorporated Nanogel of Nabumetone </title>

    <authors>
	 


      <author>
       <name>Vrushali R. Jadhav</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Kiran B. Erande</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Pharmaceutics, M.G.V’s Pharmacy College Panchavati, Nashik, Maharashtra, Affiliated to Savitribai Phule Pune University, Maharashtra, India</affiliationName>
    

		
		<affiliationName affiliationId="2"> Department of Pharmaceutics, M.G.V’s S.P.H. College of Pharmacy, Malegaon Camp, Affiliated to Savitribai Phule Pune University, Maharashtra, India</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">The objective of this research was to improve the solubilization, dissolution rate, and thereby anti-inflammatory activity of the BCS class II drug Nabumetone (NSAID). A solid dispersion (SD) approach with Gelucire 50/13 was used to enhance the solubility. Microwave-induced fusion method was used for the development of SD, as it demonstrated a remarkable increase in the solubility and dissolution rate of pure drugs when compared to traditional solid dispersions. A number of parameters of the SD were evaluated in vitro, including solubility, dissolution, and Fourier Transformed Infrared Spectra obtained (FT-IR). The rate of dissolution was inclined to betterment with the drug: polymer ratio 1:0.5 showing drug release 99.60 ± 29. The objective of the work was to evolve a Nanogel for topical delivery of Nabumetone. The emulsification-diffusion method was used to create nanogel using the polymers Carbopol-940, Gelucire-50/13, and triethanolamine as gelling agents. Chitosan was added to the formulation as a biopolymer. Menthol was employed as a penetration enhancer. Using the spontaneous emulsification-diffusion method, six distinct formulations of Nabumetone-loaded Nanogel were successfully created and evaluated for particle size, zeta potential, thermodynamic stability, and rheology study. Using a cellophane membrane, the gels were examined for diffusion study further, and drug content, viscosity, spreadability, pH, and clarity were accessed. The formulation F4 batch had the best in-vitro drug release profile, with a 96.04% release rate over 270 minutes. Optimized gel F4 underwent a skin irritation study on Wistar rats and passed the test. The topical application of Nabumetone as Nanogel proved to be an effective approach to drug delivery.</abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol20no4/formulation-and-evaluation-of-biopolymer-incorporated-nanogel-of-nabumetone/</fullTextUrl>



      <keywords language="eng">
        <keyword>Biopolymer; Cellophane membrane; Chitosan; Nabumetone; Nanogel; Solid dispersion</keyword>
      </keywords>

  </record>
</records>